tiprankstipranks
Trending News
More News >

Marc A Began Insider Profile

4 Followers
Marc A Began, VP & GC at Abiomed, holds 18.29K shares in AxoGen (Ticker: AXGN), holds 0.00 shares in Abiomed (Ticker: ABMD).
tipranks
Marc A Began

Marc A Began
Abiomed (ABMD)
VP & GC

Not Ranked
Marc A Began has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$319K
100.00%
A breakdown of Marc A Began's holdings

Insider Roles

AxoGen
(AXGN)
EVP & GC
Roles that Marc A Began holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Marc A Began

Marc A Began's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ABMD
Abiomed
Dec 27, 2022
Uninformative Sell
$0.00
AxoGen
Mar 05, 2025
EVP & GC
Uninformative Buy
332.15K
$319.07K
List of latest transactions for each holding click on a transaction to see Marc A Began's performance on stock

Marc A Began insider profile FAQ

What is the percentage of profitable transactions made by Marc A Began?
The percentage of profitable transactions made by Marc A Began is ―.
    What is the average return per transaction made by Marc A Began?
    The average return per transaction made by Marc A Began is ―.
      What stocks does Marc A Began hold?
      Marc A Began holds: ABMD, AXGN stocks.
        What was Marc A Began’s latest transaction?
        Marc A Began latest transaction was an Uninformative Buy of $332.15K.
          What was Marc A Began's most profitable transaction?
          Marc A Began’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Marc A Began's role in Abiomed?
            Marc A Began's role in Abiomed is VP & GC.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.